
10 June 2022
Goodbody Health Inc.
("Goodbody", or the "Company")
AGM, plan to de-list from the CSE, re-domicile to
Aligns With Company's Substantial
Redomicile to
Goodbody Health (AQSE: GDBY) today announces its intention to de-list from the Canadian Securities Exchange ("CSE") and to re-domicile the Company from the Province of
Goodbody has a substantial business presence in the
Goodbody does not anticipate any impact for employees, day-to-day operations, or products and services as a result of the re-domiciliation, and Goodbody intends to retain its listing on the AQSE Growth Market in
Goodbody's Board of Directors believes that the proposed plan to change its location of incorporation from the Province of
· Positions the Company in proximity to a leading global financial centre and
· Elevates the Company's visibility among potential
· Positions the Company to allow future earnings and cash flows to more efficiently fund its ongoing
· Reduces the costs and time spent procuring that the Company complies with the requirements associated with two material listings that have entirely different regulatory regimes which will allow management to focus on commercial activities; and
· Reduces currency risk.
Shareholders will have the opportunity to vote on the proposed plan at the annual general and special meeting expected to be held in August 2022. Subject to shareholder approval, the Company anticipates that the change of the place of incorporation will become effective later in the third quarter of 2022.
Shareholders' will continue to hold the exact number of shares, as they currently hold in Goodbody Health common shares and their shareholdings will be unchanged following the re-domiciliation. As the Company will be subject to the laws of
The Company expects to publish a circular to propose the CSE de-listing of the Company and re-domiciliation to
Change of Corporate Adviser
Goodbody is pleased to announce that it has appointed Peterhouse Capital Limited as the Company's Corporate Adviser with immediate effect.
Geremy Thomas, Executive Chairman, said: "With our clear strategic plan ahead of us we have to prioritise what is best for the shareholders. Following a lot of feedback, we have decided we need to simplify the business structure to enable us to focus our resources on growing what is becoming a very exciting business."
You can find further information about the Company and its strategic direction in the Financial Statements and Management Discussion and Analysis under the Company's profile on www.sedar.com.
About Goodbody (CSE: GDBY)
Goodbody is a
The directors of the Company accept responsibility for the contents of this announcement.
For further information:
Marc Howells Chief Executive Officer Goodbody Health Inc. +44 (0) 20 7971 1255 enquiries@goodbodyhealth.com |
Anne Tew Chief Financial Officer Goodbody Health Inc. +44 (0) 20 7971 1255 enquiries@goodbodyhealth.com
|
|
AQSE Corporate Adviser Peterhouse Capital Limited Guy Miller/Mark Anwyl +44 (0) 20 7469 0930 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.